Primerica (PRI) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
Fiscal 2025 saw solid financial performance with adjusted net operating income ROAE of 33.1%, $450 million in share repurchases, and a 26% increase in annual dividends to $4.16 per share.
Total stockholder return for 2025 was -3.3%, but five-year TSR reached 107.1%, outperforming the S&P 400 MidCap Index.
The company continues to focus on serving middle-income families, leveraging a diverse independent sales force, and maintaining a strong corporate culture recognized by multiple workplace awards.
Strategic growth pillars include expanding digital experiences, deepening talent, and enhancing the company’s image.
Voting matters and shareholder proposals
Stockholders will vote on electing nine directors, an advisory say-on-pay vote, and ratification of KPMG LLP as the independent auditor for 2026.
All board proposals are recommended for approval.
Proxy access allows groups holding at least 3% of shares for three years to nominate directors.
Board of directors and corporate governance
The board consists of eleven members, with two vacancies expected after the annual meeting due to retirements.
73% of board members are independent, with significant gender and racial diversity.
Board leadership is separated between a non-executive chairman and an independent lead director.
Annual board and committee self-assessments are conducted, with biannual third-party facilitation.
Directors are subject to overboarding policies and mandatory retirement age.
Latest events from Primerica
- Record ISP sales and asset growth fueled double-digit earnings and capital returns.PRI
Q4 202513 Apr 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 annual meeting.PRI
Proxy filing2 Apr 2026 - Record 2025 financials and robust capital returns highlight scalable growth and strong risk management.PRI
Investor presentation25 Mar 2026 - Record ISP sales and 8% revenue growth drove higher earnings and capital returns.PRI
Q3 20253 Feb 2026 - Adjusted EPS up 18% and record sales force, despite Senior Health exit and impairment.PRI
Q2 20242 Feb 2026 - Q3 2024 net income from continuing operations rose 24% on 11% revenue growth.PRI
Q3 202415 Jan 2026 - Double-digit growth, record sales force, and a 16% dividend hike highlight Q4 results.PRI
Q4 202417 Dec 2025 - 2024 saw record financial results, robust governance, and expanded ESG initiatives.PRI
Proxy Filing1 Dec 2025 - Vote on directors, executive pay, and auditor ratification at the May 2025 annual meeting.PRI
Proxy Filing1 Dec 2025